DARE BIOSCIENCE INC. - COMMON STOCK

Daré Bioscience Reports Third Quarter 2024 Financial Results and Provides Company Update

14 نوفمبر 2024 16:01:00 بحسب Nasdaq GlobeNewswire

Daré Bioscience Announces Grant to Support Development of a Novel Non-Hormonal Contraceptive Candidate and Expansion of Ovaprene® Pivotal Study Clinical Trial Sites

13 نوفمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Daré Bioscience to Host Third Quarter 2024 Financial Results and Company Update Conference Call and Webcast on November 14, 2024

07 نوفمبر 2024 08:00:01 بحسب Nasdaq GlobeNewswire

Daré Bioscience Selected to Receive $10 Million Award from ARPA-H’s Sprint for Women’s Health

23 أكتوبر 2024 12:30:00 بحسب Nasdaq GlobeNewswire